Brown Advisory’s CollPlant Biotechnologies CLGN Stock Holding History
Bought
Maintained
Sold
Other funds holding CLGN
PA
SDJVC
LWMI
WPC
XT
FIA
Brown Advisory's CLGN Position: Q2 2026 in Review
Brown Advisory reduced its CollPlant Biotechnologies (CLGN) stake by 12% in Q2 2026, selling an estimated $5.39K and leaving 10,473 shares worth $36.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1439.
Brown Advisory first reported a position in CLGN in Q1 2021 and has held it in 21 quarters since. The position peaked at $1.04M in Q3 2021. 15 funds tracked by Wall St. Rank hold CLGN as of Q2 2026.
- Brown Advisory held 10,473 shares of CollPlant Biotechnologies worth $36.5K as of Q2 2026.
- Brown Advisory sold 1,400 CollPlant Biotechnologies shares in Q2 2026, an estimated $5.39K.
- CollPlant Biotechnologies made up ﹤0.01% of Brown Advisory's portfolio in Q2 2026, its #1439 holding.
- Brown Advisory first reported a position in CollPlant Biotechnologies in Q1 2021 and has held it in 21 quarters since.
- Brown Advisory's CollPlant Biotechnologies position peaked at $1.04M in Q3 2021.
- 15 funds tracked by Wall St. Rank held CollPlant Biotechnologies as of Q2 2026.
Based on Brown Advisory's 13F filing for Q2 2026, filed 14 Aug 2026.